The effect of hydroxytyrosol and its nitroderivatives on catechol-O-methyl transferase activity in rat striatal tissue

Hydroxytyrosol is a well-known phenolic compound with antioxidant properties that is found in virgin olive oil. Studies have shown that virgin olive oil has neuroprotective effects in rats; thus the purpose of the present study was to investigate the neuroprotective effect of hydroxytyrosol in rats. Additionally, this study aimed to investigate the neuroprotective potential of a homologous series of compounds with better lipophilic profiles in order to increase the assortment of compounds with a putative effect against Parkinson's disease (PD). In this context, the inhibition of catechol-O-methyl transferase (COMT) activity by hydroxytyrosol, nitrohydroxytyrosol, nitrohydroxytyrosol acetate and ethyl nitrohydroxytyrosol ether was investigated by measuring intracellular dopamine and its metabolite levels in the corpus striatum by high performance liquid chromatography (HPLC) with electrochemical detection. The animals received an acute (single dose; 20 mg kg−1; i.p.) or chronic (one daily dose for 5 days; 20 mg kg−1; i.p.) treatment of hydroxytyrosol and its nitroderivatives. For comparison, a commercial COMT inhibitor, Ro 41-0960, was also included. Our data show that acute and chronic systemic administration of these compounds produced a clear and statistically significant increase in the intracellular levels of dopamine and its metabolite, 3,4-dihydroxyphenylacetic acid. The increase in dopamine levels was very similar to the increase seen with Ro 41-0960 treatment. The effect of chronic treatment was stronger than that of acute treatment. With respect to the intracellular level of homovanillic acid, Ro 41-0960 produced a statistically significant decrease which it was not observed when hydroxytyrosol and its nitroderivatives were systemically administered. However, the chronic homovanillic acid treatment effect was stronger than the acute treatment. The results suggest that these compounds could inhibit COMT activity.

[1]  D. Mcclements,et al.  What Makes Good Antioxidants in Lipid-Based Systems? The Next Theories Beyond the Polar Paradox , 2015, Critical reviews in food science and nutrition.

[2]  B. Sarriá,et al.  Synthesis and antioxidant activity of nitrohydroxytyrosol and its acyl derivatives. , 2014, Journal of agricultural and food chemistry.

[3]  M. Santiago,et al.  In vivo striatal measurement of hydroxytyrosol, and its metabolite (homovanillic alcohol), compared with its derivative nitrohydroxytyrosol , 2014, Neuroscience Letters.

[4]  J. Lecomte,et al.  The physico-chemical basis of phenolic antioxidant activity , 2014 .

[5]  Jian-Guo Jiang,et al.  Hydroxytyrosol and its potential therapeutic effects. , 2014, Journal of agricultural and food chemistry.

[6]  Ying Zhang,et al.  Lipophilic phenolic compounds (Lipo-PCs): emerging antioxidants applied in lipid systems , 2014 .

[7]  Paul J. Harrison,et al.  Sexually Dimorphic Effects of Catechol-O-Methyltransferase (COMT) Inhibition on Dopamine Metabolism in Multiple Brain Regions , 2013, PloS one.

[8]  B. Sarriá,et al.  Nitroderivatives of olive oil phenols protect HepG2 cells against oxidative stress. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  R. Bernini,et al.  Synthesis and structure/antioxidant activity relationship of novel catecholic antioxidant structural analogues to hydroxytyrosol and its lipophilic esters. , 2012, Journal of agricultural and food chemistry.

[10]  K. Gavazov.  Nitroderivatives of catechol: from synthesis to application. , 2012, Acta chimica Slovenica.

[11]  G. Tzortzis,et al.  BbgIV Is an Important Bifidobacterium β-Galactosidase for the Synthesis of Prebiotic Galactooligosaccharides at High Temperatures. , 2012, Journal of agricultural and food chemistry.

[12]  E. Kalso,et al.  Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats 1 , 2011, European journal of pain.

[13]  M. Redondo-Horcajo,et al.  Acetylation of hydroxytyrosol enhances its transport across differentiated Caco-2 cell monolayers , 2011 .

[14]  F. Visioli,et al.  Extra virgin olive oil's polyphenols: biological activities. , 2011, Current pharmaceutical design.

[15]  L. Goya,et al.  Hydroxytyrosol induces antioxidant/detoxificant enzymes and Nrf2 translocation via extracellular regulated kinases and phosphatidylinositol-3-kinase/protein kinase B pathways in HepG2 cells. , 2010, Molecular nutrition & food research.

[16]  Kou-San Ju,et al.  Nitroaromatic Compounds, from Synthesis to Biodegradation , 2010, Microbiology and Molecular Biology Reviews.

[17]  Maria João Bonifácio,et al.  Discovery of a long-acting, peripherally selective inhibitor of catechol-O-methyltransferase. , 2010, Journal of medicinal chemistry.

[18]  M. A. Martín,et al.  The olive oil phenol hydroxytyrosol enhances antioxidant/detoxificant enzymes activity and Nrf2 translocation via ERKs and PI3K/AKT pathways in HepG2 cells , 2010 .

[19]  J. Fernández-Bolaños,et al.  Synthesis of Hydroxytyrosyl Alkyl Ethers from Olive Oil Waste Waters , 2009, Molecules.

[20]  J. González-Correa,et al.  Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia–reoxygenation , 2008, Neuroscience Letters.

[21]  R. Torre.  Bioavailability of olive oil phenolic compounds in humans , 2008, Inflammopharmacology.

[22]  P. Soares-da-Silva,et al.  Catechol-O-methyltransferase and its inhibitors in Parkinson's disease. , 2007, CNS drug reviews.

[23]  C. Hertweck,et al.  Biosynthesis of Nitro Compounds , 2007, Chembiochem : a European journal of chemical biology.

[24]  L. Goya,et al.  Effect of the olive oil phenol hydroxytyrosol on human hepatoma HepG2 cells , 2007, European journal of nutrition.

[25]  J. Bautista,et al.  Lipophilic hydroxytyrosyl esters. Antioxidant activity in lipid matrices and biological systems. , 2006, Journal of agricultural and food chemistry.

[26]  B. Damaj,et al.  Hydrolyzed olive vegetation water in mice has anti-inflammatory activity. , 2005, The Journal of nutrition.

[27]  P. Soares-da-Silva,et al.  Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferase. , 2004, Journal of medicinal chemistry.

[28]  H. Teräväinen,et al.  Clinical advantages of COMT inhibition with entacapone – a review , 2004, Journal of Neural Transmission.

[29]  C. Wielinski,et al.  Frequency, Reasons, and Risk Factors of Entacapone Discontinuation in Parkinson Disease , 2004, Clinical neuropharmacology.

[30]  M. Karlsson,et al.  Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone , 2004, European Journal of Clinical Pharmacology.

[31]  P. Soares-da-Silva,et al.  BIA 3-202, a Novel Catechol-O-Methyltransferase Inhibitor, Reduces the Peripheral O-Methylation of L-DOPA and Enhances Its Availability to the Brain , 2003, Pharmacology.

[32]  P. Soares-da-Silva,et al.  Pharmacokinetics and Pharmacodynamics of BIA 3-202, a Novel COMT Inhibitor, during First Administration to Humans , 2003, Drugs in R&D.

[33]  F. Visioli,et al.  Biological Properties of Olive Oil Phytochemicals , 2002, Critical reviews in food science and nutrition.

[34]  J. Benes,et al.  Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase. , 2002, Journal of medicinal chemistry.

[35]  D. Caruso,et al.  Urinary excretion of olive oil phenols and their metabolites in humans. , 2001, Metabolism: clinical and experimental.

[36]  C. Colosimo.  The rise and fall of tolcapone , 1999, Journal of Neurology.

[37]  F. Assal,et al.  Tolcapone and fulminant hepatitis , 1998, The Lancet.

[38]  J. Prince,et al.  A cell culture model of cerebral ischemia as a convenient system to screen for neuroprotective drugs. , 1998, Journal of neural transmission. Supplementum.

[39]  P. Soares-da-Silva,et al.  Studies on the tight-binding nature of tolcapone inhibition of soluble and membrane-bound rat brain catechol-O-methyltransferase. , 1997, The Journal of pharmacology and experimental therapeutics.

[40]  Robert A. Copeland,et al.  Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis , 1996 .

[41]  Ronald Gieschke,et al.  Integrated pharmacokinetics and pharmacodynamics of the novel catechol‐O‐methyltransferase inhibitor tolcapone during first administration to humans , 1995, Clinical pharmacology and therapeutics.

[42]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[43]  L. Packer,et al.  Antioxidant properties of nitecapone (OR-462). , 1992, Free radical biology & medicine.

[44]  R. Wurtman,et al.  Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study , 1992, Brain Research.

[45]  E. Nissinen,et al.  Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462. , 1989, Biochemical pharmacology.